Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
18.07
-0.39 (-2.11%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Amneal Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Amneal Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $20.75. The average 1-year stock price forecast is 14.83% higher than the current stock price, while the lowest is $16 (-11.46%) and the highest is $25 (+38.35%).
Price Target: $20.75 (+14.83%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Amneal Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 2 | 2 | 2 |
| Buy | 3 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Buy Maintains $23 → $25 | Buy | Maintains | $23 → $25 | +38.35% | Aug 3, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Reiterates $19 → $21 | Buy | Reiterates | $19 → $21 | +16.21% | Jul 31, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $17 | Buy | Reiterates | $17 | -5.92% | Jul 20, 2026 |
| Barclays | Barclays | Buy Maintains $16 | Buy | Maintains | $16 | -11.46% | Jun 11, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 23, 2026 |
Financial Forecast
Revenue This Year
3.14B
from 3.02B
Increased by 4.13%
Revenue Next Year
3.39B
from 3.14B
Increased by 7.77%
EPS This Year
1.01
from 0.83
Increased by 21.11%
EPS Next Year
1.18
from 1.01
Increased by 17.65%
EPS and Forward PE are based on non-GAAP adjusted numbers.